
How Zeelab Is Turning Its Affordable Pharma Play Into A ₹200 Cr Business
Zeelab is aiming to double its ₹110 Cr FY26 operating revenue in FY27 on the back of its owned-store network Affordable medicines remain Zeelab’s core USP, with the company cutting

















